Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
VKTX
3 quarters
Position history for BlackRock Finance, Inc.'s holdings in Viking Therapeutics, Inc.
As of its last 13F, for Q2 2024, BlackRock Finance held 6,026,131 shares of VKTX (Viking Therapeutics), worth $319.4M. It reduced the position by 2,248,043 shares (-27.2%) from Q1 2024. BlackRock Finance held VKTX from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
$319.4M
Current Shares
6M
Total Value Change
+$177.9M
Total Shares Change
-1.6M
Quarter-by-Quarter History
Other major holders of VKTX: FMR LLC, Vanguard Group Inc.